News stories from 2026
Groundbreaking cancer treatment trial begins at QEHB
A pioneering clinical trial offering new hope to melanoma patients has launched at Queen Elizabeth Hospital Birmingham (QEHB), with Kevin Hobbs, 34, from Telford becoming the first person in the West Midlands to receive the innovative treatment.
Pioneering trial to ensure arthritis treatment suitable for cancer immunotherapy patients
Cancer patients being treated with immunotherapy called checkpoint inhibitors often experience arthritis as a side effect. The first clinical trial of its kind in the UK is now open to test whether a powerful arthritis treatment is suitable for patients receiving ongoing cancer treatment.
Review led by researchers highlights potential treatment for alcohol use disorder
University Hospitals Birmingham colleagues are among the authors of an international research paper recently published in The Lancet. Led by Dr Pouya Ebrahimi, Specialty Registrar in Cardiology, and Dr Yash Kachela, Medical Student Undergraduate, the study examines how diabetes and weight management medicines may support people living with alcohol use disorder.
Birmingham researchers lead state-of-the-art review on heart disease in chronic kidney disease
Researchers from University Hospitals Birmingham and the University of Birmingham have carried out a commissioned state-of-the-art review on heart disease in chronic kidney disease (CKD).